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Summary  The  diagnosis  of  a latent  tuberculosis  infection  (LTBI)  is  of  the  utmost
concern.  The  available  tests,  the  tuberculin  skin  test  (TST)  and  the  Quantiferon-
TB  Gold  test  (QFT-G)  cannot  discriminate  between  active  TB  and  LTBI.  Therefore,
the  aim  of  the  study  is  to  identify  new  biomarkers  that  can  discriminate  between
active  TB  and  LTBI  and  can  also  assess  the  risk  of  the  individual  developing  active
TB.  In  total,  55  blood  samples  were  collected,  of  which  10  samples  were  from  the
active  TB  infection  group,  10  were  from  the  high-risk  exposure  group,  23  were  from
the  low-risk  exposure  group,  and  12  were  from  healthy  controls  living  in  a  non-TB
endemic  area.  A  panel  of  heat  shock  proteins  (Hsps),  including  host  Hsp25,  Hsp60,
Hsp70,  and  Hsp90  and  Mycobacterium  tuberculosis  (MTB)  Hsp16,  were  evaluated
in  all  of  the  collected  samples  using  ELISA.  The  levels  of  the  host  Hsp(s)  (Hsp25,
Hsp60,  Hsp70  and  Hsp90)  and  MTB  Hsp16  were  signiﬁcantly  (p  <  0.05)  elevated  in  the
active  TB  group  compared  to  the  high-risk  exposure  group,  the  low-risk  exposure
group  and  the  control  group.  Notably,  the  levels  of  the  same  panel  of  Hsp(s)  were
elevated  in  the  high-risk  exposure  group  compared  to  the  low-risk  exposure  group.
On  follow-up,  out  of  the  10  high-risk  exposure  participants,  3  converted  into  active
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Introduction
Tuberculosis  (TB)  is  the  largest  health  problem  in
the world.  Approximately  one-third  of  the  world’s
population is  latently  infected  with  Mycobacterium
tuberculosis  (MTB),  and  10%  of  latently  infected
individuals will  develop  active  TB  during  their  life-
time. Identifying  latently  infected  individuals  is
part of  the  global  plan  for  TB  control  [1]. Many
studies have  reported  markers  that  can  differen-
tiate between  active  and  latent  TB-infected  (LTBI)
individuals  [2,3]. Traditionally,  the  diagnosis  of  LTBI
has relied  on  the  tuberculin  skin  test  (TST)  [4];  how-
ever, the  TST  has  several  limitations,  including  a
high rate  of  false-positive  results  among  individuals
vaccinated with  Bacillus  Calmette-Guérin  (BCG)  or
exposed to  non-TB  mycobacteria  [5,6].  Regardless
of their  reported  sensitivities,  T-cell-based  inter-
feron gamma  (IFN-)  release  assays  (IGRAs)  [7,8]
have  been  approved  for  the  diagnosis  of  LTBI  [9].
However,  the  two  commercially  available  IGRAs,
the QuantiFERON  TB-Gold  test  (Cellestis,  Victo-
ria, Australia)  and  the  T-SPOT  TB  test  (Oxford
Immunotec, Abington,  UK),  fail  to  distinguish  active
disease from  LTBI  [10,11]. Therefore,  there  is  a
need to  explore  new  markers  that  can  discriminate
between active  TB  and  LTBI  and  can  serve  as  alter-
native  or  additional  immunological  biomarkers  of
the disease  status.
Heat  shock  proteins  (Hsps)  have  recently
received a  great  deal  of  attention  as  promis-
ing biomarkers  for  TB  infection  [12—14]  and  have
been shown  to  share  diverse  functions,  such  as
the control  of  protein  degradation,  thermotoler-
ance [15—17],  immunomodulation  and  regulation
of development  and  evolution  [18].  Hsp(s)  provide
a natural  link  between  the  innate  and  adaptive
immune responses  [19]. They  function  as  chap-
erones and  co-chaperones,  binding  intracellular
polypeptide chains  and  misfolded  proteins,  pre-
venting  aggregation  and  supporting  folding  and
transport  [20].  Our  earlier  ﬁndings  suggest  that
Hsp65 and  Hsp71  can  be  used  for  the  diagnosis
of TB  [14,21].  We  have  also  reported  that  Hsp16
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p  has  the  highest  risk  of  developing  TB.  Thus,  the  eval-
iscriminate  between  LTBI  and  active  TB.  They  can  also
t  the  highest  risk  of  developing  active  TB.  Because  they
p(s)  have  an  edge  over  the  existing  diagnostic  tools  for
e  proteins  will  be  useful  in  designing  better  diagnostic
ziz  University  for  Health  Sciences.  Published  by  Elsevier
s  more  speciﬁc  to  latency  and  can  be  used  as  a
iagnostic  marker  for  LTBI  [22]. Therefore,  with
egard to  the  available  literature  and  our  previ-
us ﬁndings,  we  aim  to  evaluate  a panel  of  host
sp25, Hsp60,  Hsp70,  and  Hsp90  and  MTB  Hsp16  in
he serum  samples  of  participants  that  have  house-
old contact  with  active  TB  cases  to  screen  for
TBI. The  selected  population  has  high  crowding
ndex in  their  homes,  poor  socioeconomic  status
nd unhygienic  living  conditions.  These  risk  factors
ay increase  the  transmission  of  TB  in  the  popu-
ation.  We  hypothesize  that  the  selected  panel  of
ost and  MTB  Hsp(s)  will  be  differentially  expressed
mong the  selected  groups.
aterials and methods
he  present  study  was  conducted  in  a high  TB
ndemic  area  in  the  Nagpur  district  of  Maharashtra,
ndia. As  per  the  local  health  care  center  report,  the
nnual risk  of TB  infection  in  this  community  region
s very  high.  The  community  has  a  high  household
rowding index,  with  an  average  of  6—8  members
iving in  small,  closed  rooms,  which  increases  the
isk of  disease  transmission  among  family  members.
 total  of  43  blood  samples  were  collected  from
ight families  living  in  this  TB  endemic  area.  Twelve
articipants  were  recruited  from  an  area  where  the
nnual risk  of  TB  infection  is  very  low,  as  reported
y a  local  health  care  center.  The  blood  samples
ollected from  these  participants  were  considered
o be  healthy  controls  for  the  analysis.
The  participants  were  given  an  oral  explanation
f the  study,  and  written  consent  was  obtained
rom all  of  them.  The  study  was  approved  by  Ethi-
al Committee  of  Central  India  Institute  of  Medical
ciences,  (CIIMS),  (01/CIIMS/Hsps/09/13)  Nagpur.
tudy group deﬁnitionctive  TB  group  (n  =  10)
his  group  includes  family  members  (TB  index
ases) aged  17—55  years  who  have  conﬁrmed
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weat  shock  proteins  in  latent  TB  infection  
ulmonary  TB,  as  diagnosed  on  positive  chest
-ray, sputum  smear  and  culture  results,  and/or
heir response  to  TB  treatment.
xposed  group  (n  = 33)
hirty-three  household  contacts  whose  age  ranged
rom 14  to  55  years  were  recruited  from  families
here there  was  at  least  one  sputum-positive  pul-
onary  TB  patient  (index  case)  living  in  the  same
ousehold  for  at  least  3  months  before  the  start
f the  treatment.  This  group  was  divided  into  two
ategories:
(a) High-risk  exposure  group  (n  =  10)
Ten household  contacts  aged  14—40  years
who had  QFT-G  and/or  TST  positive  results  but
no clinical  or  radiological  evidence  of  active  TB
were recruited  in  this  group.  High-risk  expo-
sure was  deﬁned  as  prolonged  contact  with
sputum smear-  and  chest  X-ray-positive  TB
patients  lasting  for  more  than  8  h.  This  group
included spouses  and  children  of  TB  patients.
Participants were  interviewed  using  a  standard
questionnaire and  were  then  followed  up  for
8 months.  Information  on  whether  they  subse-
quently developed  active  TB  was  ascertained
from the  records  of  their  local  healthcare  cen-
ters.
b) Low-risk  exposure  group  (n  =  23)
Twenty-three  household  contacts  aged  14—55
years who  had  QFT-G  and/or  TST  positive
results but  no  clinical  or  radiological  evidence
of active  TB  were  in  included  in  this  group.
Low-risk exposure  was  deﬁned  as  infrequent
or short-lived  contact  with  sputum  smear-  and
chest  X-ray-positive  TB  patients.  This  group
included extended  family  members  of  active  TB
patients.  Participants  were  interviewed  using
a standard  questionnaire  and  were  then  fol-
lowed up  for  8 months.  Information  on  whether
they subsequently  developed  active  TB  was
ascertained from  the  records  of  their  local
healthcare centers.
ontrols  (n  =  12)
welve  absolutely  healthy  controls  (14—55  years)
ho  had  the  same  ethnicity  were  included  in  this
roup.  The  healthy  individuals  had  no  infection  and
o exposure  with  TB  index  cases,  were  QFT-G  and
ST negative  and  had  a  normal  chest  X-ray.  The  con-
rols belonged  to  a  non  TB-endemic  area  of  India.lood and serum samples
enous  blood  was  collected  from  all  of  the  par-
icipants included  in  the  study.  The  hematological
a
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arameters  were  evaluated  in  the  collected
lood samples  using  a Beckman  Coulter  Ac.T  5diff
nalyzer.  The  blood  samples  collected  in  plain
accutainers were  allowed  to  clot  and  centrifuged
t 2000  rpm  for  2  min  to  collect  the  serum.  All  of
he serum  samples  were  stored  at  −20 ◦C  until  use.
ntibodies
rimary  antibodies
 monoclonal  antibody  against  Hsp16  (alpha-
rystalline-Rv2031c)  was  obtained  from  Colorado
tate University,  USA,  under  the  TB  Research
aterials and  Vaccine  Testing  Contract  (NO1-
I-75320). Monoclonal  antibodies  against  human
sp(s) (Hsp25,  Hsp60,  Hsp70  and  Hsp90)  were
btained  from  SIGMA  Aldrich  (USA).
econdary  antibody
he  horse  radish  peroxidase  (HRP)-conjugated
econdary  antibody  was  obtained  from  Genei,  Ban-
aluru, India.  It  was  raised  in  rabbit  against  mouse
gG, i.e.,  Rabbit  anti-mouse  IgG  HRP.
nzyme-linked immunosorbent assay
ELISA)
ach  set  of  microtiter  wells  was  coated  with  100  l
f serum  samples  at  different  dilutions  for  different
sp(s)  and  incubated  at  37 ◦C  for  90  min.  The  serum
ilutions  for  different  Hsps  are  as  follows:  the  host
sp25 was  1:200,  host  Hsp60  and  70  were  1:400,
ost  Hsp90  was  1:100  and  MTB  Hsp16  was  1:400.
he plates  were  then  washed  once  with  1×  phos-
hate buffered  saline  (PBS),  and  100  l  of  blocking
uffer (BSA)  was  added  per  well.  The  plates  were
ncubated at  37 ◦C  for  45  min.  After  incubation,  the
lates were  washed  three  times  with  1×  PBS,  and
00 l  of  a  primary  antibody  solution,  i.e.,  mono-
lonal antibodies  generated  against  Hsp(s)  (Host
sp25 1:8000,  Hsp60  1:5000,  Hsp70  1:10,000,  Hsp90
:4000 and  MTB  Hsp16  1:5000)  were  separately
dded to  each  well  followed  by  incubation  at  37 ◦C
or 45  min.  The  wells  were  then  subjected  to  wash-
ng with  1×  PBS  three  times,  and  100  l  of  the
econdary antibody  (Rabbit  anti  mouse)  solution
Host Hsp25  1:2000;  Hsp  60,  70  and  90  1:4000
nd MTB  Hsp16  1:10,000)  was  then  added  followed
y incubation  at  37 ◦C  for  45  min.  The  wells  were
ashed three  times  with  1×  PBS  followed  by  the
ddition of  100  l  of  the  substrate  TMB/H2O2 per
ell. The  wells  were  incubated  for  5—10  min,  after
hich the  reaction  was  stopped  with  the  addi-
ion of  100  l  of  2.5  N H2SO4. The  absorbance  of
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color  in  each  well  was  read  at  450  nm  on  an  ELISA
reader.
Statistical analysis
Statistical  analysis  was  performed  using  Graph-
Pad Prism  (version  5.03).  Analysis  was  performed
using one-way  ANOVA.  Dunnett’s  multiple  compari-
son post-test  was  carried  out  to  test  the  signiﬁcance
of the  difference  in  the  mean  levels  of  the  Hsp(s)
for the  four  study  groups.  Categorical  variables
were described  as  the  mean  ±  standard  deviation
(SD).
Results
The  characteristics  of  the  population  are  described
in Table  1.
It was  observed  that  most  of  the  population
is illiterate  and  that  20%,  40%  and  47.8%  of  the
active TB,  high-risk  exposure  and  low-risk  expo-
sure groups,  respectively,  had  received  a  primary
school  education.  More  than  50%  of  the  population
is underweight.  In the  active  TB  group,  80%  of  the
participants  had  weight  loss,  40%  had  cough  with
expectorant,  30%  had  cough  without  expectorant,
80% had  a fever,  30%  had  stomach  pain  and  20%  of
the population  had  chest  pain.  In  the  high-risk  expo-
sure group,  only  1  (10%)  participant  had  fever  and
complained  of  weight  loss.  In  the  low-risk  exposure
group, 2  (8.69%)  of  the  participants  complained  of
fever. The  information  was  collected  using  a struc-
tured questionnaire  at  the  time  of  recruitment  of
the participants.
The  mean  hematological  parameters  of  the
active TB,  high-risk  exposure,  low-risk  exposure  and
control participants  are  shown  in  Table  2.  It  was
observed  that  the  levels  of  the  total  white  blood
cell (WBC)  count;  the  percentage  of  polymorphs,
eosinophils,  and  monocytes;  and  the  erythrocyte
sedimentation  rate  (ESR)  were  highest  in  the  TB
group compared  to  the  other  groups.  Notably,  the
level of  the  same  parameters  was  increased  in
the high-risk  exposure  group  compared  to  the  low-
risk exposure  group,  indicating  the  alertness  of  the
immune system  in  the  individuals  of  the  former
group.
Fig.  1(a—d)  shows  a  scatter  plot  of  Hsp25,  Hsp60,
Hsp70 and  Hsp90  in  the  serum  samples  of  the  active
TB (n  =  10),  high-risk  exposure  (n  = 10),  low-risk
exposure (n  =  23)  and  control  groups  (n  =  12)  as  well
as their  p  values.  The  level  of  Hsp25  in  the  active
TB group  was  signiﬁcantly  (p  < 0.05)  increased  com-
pared to  the  healthy  controls.  The  level  of  the  same
n
c
c
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sp  was  also  increased  in  the  high-risk  exposure
p <  0.05)  and  low-risk  exposure  groups  (p  <  0.05)
ompared  to  the  healthy  controls.  Similarly,  it  was
bserved that  the  level  of  Hsp60  was  also  sig-
iﬁcantly increased  in  the  serum  samples  of  the
ctive TB  (p  < 0.05)  and  high-risk  exposure  (p  <  0.05)
roups compared  to  the  healthy  individuals  of  the
ontrol group.  Although  the  level  of  Hsp60  was
ncreased  in  the  low-risk  exposure  group  compared
o the  healthy  control,  the  p  value  was  not  signif-
cant. A  signiﬁcant  increase  in  the  level  of  Hsp70
as observed  in  the  active  TB  group  (p  <  0.05)
nd the  high-risk  exposure  group  (p  <  0.05)  com-
ared to  the  healthy  group.  Although  the  level
f Hsp70  was  increased  in  the  low-risk  exposure
roup compared  to  the  healthy  control,  the  p  value
as not  signiﬁcant.  The  level  of  host  Hsp90  was
lso increased  in  the  active  TB  (p  <  0.05),  high-risk
xposure  (p  <  0.05)  and  low-risk  exposure  groups
p >  0.05)  compared  to  the  control  group.  Notably,
 higher  mean  value  was  observed  for  all  of  the
ost Hsp(s)  in  the  serum  samples  of  the  high-risk
xposure group  compared  to  that  of  the  low-risk
xposure group.
Fig.  2  shows  a scatter  plot  of  Hsp16  in  the  serum
amples of  the  active  TB  (n  =  10),  high-risk  expo-
ure (n  =  10),  low-risk  exposure  (n  = 23)  and  control
roups (n  =  12)  as  well  as  their  p values.  The  high-
st levels  of  all  of  the  Hsps  were  observed  in  the
B group,  followed  by  the  high-risk  exposure  and
ow-risk exposure  groups  compared  to  the  healthy
ontrol,  and  the  p  value  was  signiﬁcant  for  all  of
he groups.  The  p value  was  calculated  with  refer-
nce to  the  control  group  using  one-way  ANOVA  test
nd was  further  conﬁrmed  by  Dunnett’s  multiple
omparison post-test.
iscussion
n  this  study,  we  examined  a  panel  of  host  and  MTB
sp(s) to  screen  the  population  that  had  LTBI  and
lso identiﬁed  the  individuals  with  the  highest  risk
f developing  active  TB.  Our  results  showed  that
he levels  of  host  Hsp25,  Hsp60,  Hsp70,  and  Hsp90
nd MTB  Hsp16  were  signiﬁcantly  increased  in  the
B group  compared  to  the  high-risk  exposure,  low-
isk exposure  and  healthy  control  groups,  which
s consistent  with  our  previous  reports  [14,21,22].
owever, an  even  more  interesting  ﬁnding  of  this
tudy is  the  increased  levels  of  the  same  panel  of
sp(s), which  are  considered  to  be  ‘‘danger  sig-
als,’’ in  the  sera  of  the  high-risk  exposure  group
ompared  to  the  low-risk  exposure  and  healthy
ontrol groups.  Similarly,  the  same  Hsp(s)  were  ele-
ated in  the  low-risk  exposure  group  compared  to
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Table  1  Baseline  characteristics  of  the  participants.a
Characteristics  Active  TB  (n  =  10)  High-risk  exposure  (n  =  10)  Low-risk  exposure  (n  =  23)
Age  (years)
<18  2  (20)  4  (40)  10  (43.4)
18—40  7  (70)  6  (60)  9  (39.1)
40—60  1  (10)  0  4  (17.3)
Sex  (M/F)
Male  4  (40) 3  (30) 10  (43.4)
Occupation
Student  2  (20) 4  (40) 10  (43.4)
House  wife  3  (30)  5  (50)  8  (34.7)
Labor  5  (50)  1  (10)  5  (21.7)
Education
Primary  educated  2  (20)  4  (40)  11  (47.8)
BMI  (kg/m2)
Normal  2  (20)  4  (40)  5  (21.7)
Underweight  8  (80)  6  (60)  16  (69.5)
Overweight  0  0  2  (8.69)
Weight  loss
Yes  8  (80)  1  (10)  0
Cough  with  expectorant
Yes 4  (40)  0  0
Cough  without  expectorant
Yes 3  (30)  0  0
Fever
Yes 8  (80) 1  (10) 2  (8.69)
Stomach  pain
Yes 3  (30) 0  0
Chest  pain
Yes 2  (20) 0  0
Smoking
Yes  4  (40)  2  (20)  9  (39.1)
Alcohol
Yes  1  (10)  0  1  (4.34)
Tobacco
Yes  5  (50)  2  (20)  9  (39.1)
BCG
Yes  9  (90)  8  (80)  13  (56.5)
Don’t  know  1  (10)  2  (20)  7  (30.4)
Hemoglobin  (g/dl)b 12.36  12.68  12.47
a The information was gathered using structured questionnaires at the time of recruitment of the participants for study.
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wb Value of hemoglobin is a mean of all the participants recr
he  control  group,  indicating  the  activated  immune
esponse  in  household  contacts  who  only  had  indi-
ect exposure  to  TB  patients.
Many  studies  have  been  performed  to  identify
ew biomarkers  that  can  discriminate  active  TB
nd LTBI.  Hur  et  al.  have  shown  that  IL-10  and
L-17 may  help  to  differentiate  between  LTBI  and
B patients  and  that  CXCL10,  IL-17  and  TNF-
roduction  were  signiﬁcantly  higher  in  the  group  of
pouses thought  to  have  a  higher  risk  of  MTB  infec-
ion based  on  higher  ESAT-6  responses  [23].  Another
tudy  by  Crampin  et  al.  showed  that  the  spouses
f individuals  with  TB  are  a  high-risk  group  who
n
s
e in respective group.
hould  be  screened  for  active  TB.  These  studies
eport an  increased  level  of  the  evaluated  markers
n high  risk  individuals  [24]. Thus,  the  higher  level
f Hsp(s)  in  the  high-risk  exposure  group  compared
o the  low-risk  exposure  and  healthy  control  is in
greement  with  the  available  literature.
We  described  the  high-risk  exposure  group  as
amily members  who  are  living  with  conﬁrmed  pul-
onary TB  patients  and  have  close  physical  contact
ith the  TB  patient  while  sharing  bedrooms  and
ursing  the  patient.  The  close  direct  exposure  and
usceptibility  are  highlighted  by  the  increased  lev-
ls of  host  and  MTB  Hsp(s)  compared  to  the  low-risk
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Table  2  Analysis  of  hematological  parameters  in  TB  (n  =  10),  high-risk  exposure  (n  =  10),  low-risk  exposure  (n  =  23)
and  healthy  control  (n  =  12).
Parameters
[mean  with  SD]
TB (n  =  10)  High-risk
exposure  (n  =  10)
Low-risk
exposure  (n  =  23)
Control  (n  =  12)
Hemocrit  (%) 36.28  ±  5.8 37.23  ±  4.5 36.65  ±  3.98 45.23  ±  3.2
Total  WBC
(/cu.mm)
9844  ±  2355 9271  ±  1583 9072  ±  1091 6856  ±  1589
Polymorphs  (%)  62  ±  14.8  60  ±  5.9  57  ±  8.42  41  ±  1.3
Lymphocytes  (%)  31  ±  13.6  33  ±  3.6  34  ±  9.1  20  ±  2.1
Eosinophil  (%)  7  ±  3  7  ±  4.4  6  ±  3.8  0.28  ±  0.48
Monocytes  (%)  1  ±  0.9  1  ±  0.7  0  0
Basophils  (%)  0  0  0  0
ESR  (mm  at  1  h) 35  ±  1.6  21  ±  1.5  19  ±  2  2.5  ±  1.13
RBC  Count
(mil/cu.m)
4.62  ±  0.64  4.91  ±  0.35  4.73  ±  0.6  4.73  ±  0.3
MCV  (micron)  79  ±  5.75  76.5  ±  8.3  78  ±  8.2  78  ±  2.1
MCH  (picogram)  27  ±  2.64  25.93  ±  3.7  26.45  ±  3.1  27.25  ±  4.1
MCHC  (%) 34  ±  1  33.86  ±  1.5  33.90  ±  0.9  33.12  ±  0.5
Platelet  count
(/cu.mm)
355,222  ±  91,474 327,102  ±  6544  531,818  ±  81,955  531,618  ±  71,355
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wexposure  group.  The  reason  for  susceptibility  could
be the  airborne  transmission  of  MTB,  which  is  more
likely to  occur  when  the  duration  and  proximity
of the  contact  with  an  infectious  case  increases
[25—27].  The  different  Hsp  proﬁles  in  the  high-risk
exposure and  low-risk  exposure  groups  indicate  that
the former  population  is  at  high  risk  of  developing
TB. Furthermore,  the  increased  levels  of  the  hema-
tological  parameters,  such  as  the  total  WBC  count
and percentage  of  polymorphs,  eosinophils  and  ESR
in the  high-risk  exposure  group  compared  to  low-
risk exposure  group  indirectly  supports  our  results,
indicating  the  triggering  of  immune  responses  in
the participants  of  the  former  group.  These  results
were conﬁrmed  in  follow-up  studies,  which  were
performed  8  months  after  the  initial  study.  Out
of the  10  participants  in  the  high-risk  exposure
group, 3 participants  converted  to  active  TB  within
8 months  of  the  initial  study,  thus  demonstrating
that the  high-risk  exposure  group  had  the  highest
risk of  developing  disease.
Although  Hsp(s)  are  expressed  constitutively,
their expression  increases  under  stressful  con-
ditions.  In  tuberculous  infection,  Hsps  exhibit
different functions,  including  the  activation  of  toll-
like receptors  (TLRs),  eliciting  immune  responses,
acting as  a  tool  for  diagnosis  and  also  serving  as
potent vaccine  candidates  [28—30].  Several  inves-
tigators  have  reported  different  functions  of  host
Hsp(s) in  controlling  bacterial  infections.  Huang
et al.  have  shown  that  host  Hsp25  and  Hsp70
have a  role  in  thermotolerance  and  the  preven-
tion of  apoptosis  [31].  Oura  et  al.  and  Macario
p
i
c
it  al.  have  reported  the  roles  of  host  Hsp70
nd Hsp90  in  chaperoning  and  proinﬂammatory
esponses  [32,33].  Chen  et  al.  have  reported  that
ost Hsp60  has  a role  in  modulating  immunity
nd inﬂammation  by  activating  monocytes  and
acrophages  [34]. Thus,  the  host  Hsp(s)  should  be
ncreased  in  the  high-risk  exposure  group,  where
he chances  of  disease  are  the  greatest  compared
o the  low-risk  exposure  group  and  healthy  con-
rols.  It  is well  known  that  bacterial  Hsp(s)  are
ighly immunogenic  and  capable  of  inducing  anti-
ody production  and  T cell  activation  [14,21,30].
TB Hsp16  is  required  for  the  survival  of  bacteria
n the  stationary  phase,  and  therefore,  the  main-
enance  of  a  constant  cellular  level  of  this  protein
s an  important  strategy  for  MTB  to  survive  in  the
ormant  state  [35].  These  ﬁndings  are  consistent
ith the  results  obtained  for  MTB  Hsp16  in  our  test
ettings.
We previously  reported  Hsp(s)  as  promising
iomarkers in  TB  disease  [36]. In  this  preliminary
tudy, our  results  suggest  that  the  evaluated  Hsp(s)
ave the  potential  to  distinguish  individuals  with
ctive TB  and  LTBI,  thus  providing  a new  frontier  in
B research.
A study  by  Dubaniewicz  et  al.  reported  the  stage-
peciﬁc  increase  of  MTB  Hsp65  and  70  in  sarcoidosis,
hus indicating  an  increase  in  Hsps  concomitant
ith the  increase  in  infection  [37].  In  light  of  the
resent  evidence,  we  hypothesize  that  with  an
ncrease  in  exposure  to  active  TB  patients,  the
hances  of  transmitting  TB  increases  along  with  an
ncrease in  the  levels  of  Hsp(s).  A study  by  Lutong
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Figure  1  Evaluation  of  host  Hsp(s).  Host  Hsp(s)  were  evaluated  in  the  serum  samples  of  active  TB  (n  =  10),  high-risk
exposed  (n  =  10),  low-risk  exposed  (n  =  23)  and  control  (n  =  12)  participants  using  indirect  ELISA.  (a)  Hsp25,  (b)  Hsp60,
(c)  Hsp70  and  (d)  Hsp90.  Scatter  plots  represent  the  different  absorbance  levels  of  the  Hsp(s)  in  the  serum  samples
of  active  TB,  high-risk  exposed,  low-risk  exposed  and  control  subjects  from  the  average  value.  Statistical  variance
between  the  groups  was  calculated  using  the  mean  values  through  ANOVA  with  Dunnett’s  multiple  comparison  post-test
(  the
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gp  <  0.05-*).  The  p  value  was  calculated  with  reference  to
t  al.  contradicts  our  hypothesis;  however,  the  clas-
iﬁcation  of  the  study  groups  could  be  a  major
eason for  the  contradiction  [38].
In our  study,  individuals  with  active  TB  and
xposed household  contacts  live  in  small  houses
ith no  ventilation.  Overcrowding  of  the  members
n the  family  results  in  an  increased  likelihood  of
oming into  contact  with  an  active  TB  patient.
s
i
a control  group.
he  situation  is  further  aggravated  due  to  the  low
ocioeconomic  status,  unhygienic  conditions  and
oor living  conditions,  which  ultimately  leads  to  the
ransmission of the  disease.  The  high-risk  exposure
roup  consisted  of  ﬁrst-degree  relatives,  such  as
pouses, parents  and  siblings,  who  come  into  phys-
cal contact  with  active  TB  patients  while  nursing
nd sleeping  under  the  same  roof;  therefore,  there
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Figure  2  Evaluation  of  Mycobacterium  tuberculosis
Hsp16.  Mycobacterium  tuberculosis  Hsp16  was  evaluated
in  the  serum  samples  of  active  TB  (n  =  10),  high-risk
exposed  (n  =  10),  low-risk  exposed  (n  =  23)  and  control
(n  =  12)  participants  using  indirect  ELISA.  Scatter  plots
represent  the  different  absorbance  levels  of  Hsp16  in  the
serum  samples  of  active  TB,  high-risk  exposed,  low-risk
exposed  and  control  subjects  from  the  average  value.
Statistical  variance  between  the  groups  was  calculated
using  the  mean  values  through  ANOVA  with  Dunnett’s  mul-
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Rtiple  comparison  post-test  (p  <  0.05-*).  The  p  value  was
calculated  with  reference  to  the  control  group.
are  increased  chances  of  developing  TB  in  these
participants. However,  the  low-risk  exposure  group
consisted  of  members  with  distant  relationships,
such as  with  a  daughter-in-law  and  mother-in-law,
aunt/uncle, niece/nephew,  and  so  on,  who  hardly
come into  physical  contact  with  the  active  TB
patients, but  who  still  communicate  with  them  dur-
ing social  events  [39], and  therefore,  the  levels  of
Hsp(s) are  elevated  compared  to  healthy  individ-
uals.
Although  our  study  highlights  many  new  horizons
in TB  transmission,  some  limitations  remain.  The
major limitation  of  our  study  is  the  small  number
of samples.  Despite  our  extensive  efforts  to  collect
additional  samples,  our  contacts  did  not  respond
favorably due  to  community  ethics  and  a lack  of
awareness  of  medical  issues.  We  ﬁrst  evaluated  a
panel of  Hsp(s)  consisting  of  four  host  Hsps  (Hsp25,
Hsp60,  Hsp70  and  Hsp90)  and  one  MTB  Hsp  (Hsp16)
in screening  for  LTBI  in  a  TB-exposed  population
using indirect  ELISA,  which  has  an  added  advantage
of being  able  to  be  rapidly  performed  in  a  standard
laboratory with  minimal  settings.  These  biomark-
ers can  be  evaluated  in  laboratories  with  limited
resources and  technical  expertise.S.D.  Shekhawat  et  al.
onclusions
n  conclusion,  we  observed  different  levels  of  Hsp(s)
Host Hsp25,  Hsp60,  Hsp70,  and  Hsp90  and  MTB
sp16) in  the  active  TB,  high-risk  exposure,  low-
isk exposure  and  control  groups.  Thus,  evaluating
he Hsp(s)  in  the  serum  of  the  exposed  popula-
ion seems  to  be  an  ideal  tool  for  screening  LTBI
n the  developing  world,  where  the  bulk  of  TB  dis-
ase occurs.  The  evaluated  panel  of  Hsp(s)  may
iscriminate  between  LTBI  and  active  TB  patients.
hey  may  also  be  useful  for  identifying  individuals
aving the  highest  risk  of  developing  active  TB  dis-
ase. These  evaluated  Hsp(s)  might  be  useful  in
esigning  better  diagnostic  methods  for  LTBI.  The
igh-risk exposure  group  should  be  considered  to
e an  important  target  group  for  interventions  by
B control  programs.  Studies  are  needed  to  mon-
tor the  infection  in  high-risk  exposed  individuals
nd their  later  development  of  TB.  Further  stud-
es with  a higher  number  of  samples  are  clearly
arranted.
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